A previous study in 36,813 Chinese lung cancer patients, focusing on eight key lung cancer driver genes (EGFR, ALK, MET, KRAS, ERBB2, ROS1, RET, and BRAF), revealed a prevalence of 0.03% for P/LP germline mutations [30]. This evidence concerns the gene KRAS and lung cancer.